Renal bone disease in black dialysis patients: Are algorithms developed for white dialysis patients valid? [10]

Nephrology Dialysis Transplantation

Volumn 16, Issue 7, 2001, Pages 1518-1519

  Gupta, A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ALGORITHM; BLOOD LEVEL; CALCIUM METABOLISM; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH INSURANCE; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; KIDNEY FAILURE; LETTER; NEGRO; PARATHYROIDECTOMY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY;

EID: 0034947286     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.7.1518     Document Type: Letter

References (8)

1. Management of the renal patient: Experts' recommendations and clinical algorithms on renal osdeodystrophy and cardiovascular risk factors
2. Forward
3. Race is a major determinant of secondary hyperparathyroidism in uremic patients
4. Diminished rates of bone formation in normal black adults
5. Evidence for alteration of the vitamin-D endocrine system in blacks
6. Bone disease in predialysis, hemodialysis and CAPD patients: Evidence of a better bone response to PTH
7. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
8. Increased risk of hip fractures in the U.S. medicare end-stage renal disease patients